What is the appropriate prescription for celecoxib (Celebrex) for a female patient with severe arthritis who will take 200 mg twice daily with food for up to 14 days while awaiting orthopedic evaluation, including necessary precautions?

Celecoxib 200 mg Twice Daily for Severe Arthritis: Prescription Guidance

For severe arthritis requiring short-term management, celecoxib 200 mg twice daily with food for 14 days is an appropriate prescription, but you must screen for cardiovascular risk factors, assess gastrointestinal bleeding risk, verify renal function, and consider gastroprotection if indicated.

Dosing Verification

Your proposed regimen aligns with FDA-approved dosing. The FDA label specifies that for osteoarthritis, celecoxib can be dosed as 200 mg daily (as a single dose or 100 mg twice daily), while for rheumatoid arthritis, 100-200 mg twice daily is recommended 1. For acute pain management, the FDA approves 400 mg initially, followed by 200 mg as needed on day 1, then 200 mg twice daily on subsequent days 1. Your 200 mg twice daily regimen falls within approved parameters and is supported by evidence showing efficacy for severe arthritis symptoms 2, 3.

Critical Pre-Prescription Assessment

Before writing this prescription, you must evaluate:

Cardiovascular Risk:

• Celecoxib is contraindicated in patients with established cardiovascular disease, recent MI, stroke, or heart failure 4
• Screen for hypertension, as COX-2 inhibitors can elevate blood pressure by approximately 5 mm Hg 5
• Patients with >10% 10-year cardiovascular risk require extreme caution 6
• If cardiovascular risk factors exist, consider naproxen instead, as it may have less thrombotic risk than other NSAIDs 7

Gastrointestinal Risk Stratification:

• Age >65 years increases GI bleeding risk 2-3.5 fold 7
• Prior peptic ulcer or GI bleeding increases risk 2.5-4 fold 7
• Concurrent anticoagulants increase bleeding risk 3-6 fold 5
• Concurrent corticosteroids double GI event risk 7
• If patient takes low-dose aspirin, celecoxib loses much of its GI safety advantage 8, 9

Renal Function:

• Check baseline creatinine, especially in elderly patients or those with pre-existing renal disease
• NSAIDs can cause acute renal failure through impaired renal perfusion 5
• Avoid in patients with significant renal impairment

Gastroprotection Strategy

Add a proton pump inhibitor (PPI) if the patient has:

• Age >65 years
• History of peptic ulcer disease
• Concurrent aspirin use (even low-dose)
• Concurrent anticoagulant or corticosteroid use
• Multiple risk factors

The evidence shows PPIs reduce NSAID-associated symptomatic ulcers by 50-90% 4. Standard-dose PPIs (e.g., omeprazole 20 mg daily) are more effective than H2-blockers for gastroprotection 10.

Hepatic Considerations

For patients with moderate hepatic impairment (Child-Pugh Class B), reduce the dose by 50% (i.e., 100 mg twice daily instead of 200 mg twice daily) 1. Celecoxib is contraindicated in severe hepatic impairment 1.

Drug Interactions to Address

Aspirin interaction: If the patient takes aspirin for cardioprophylaxis, counsel that celecoxib may not interfere with aspirin's antiplatelet effect (unlike ibuprofen), but the combination increases GI bleeding risk substantially 9. The annual risk of upper GI events with NSAID plus aspirin is 5.6% 9.

Anticoagulants: If on warfarin, expect INR to increase up to 15% and monitor closely 5. Consider alternative pain management if possible.

The Prescription

Write it as:

• Celecoxib 200 mg capsules
• Take one capsule by mouth twice daily with food
• Dispense: 28 capsules
• Duration: 14 days (until orthopedic evaluation)
• No refills

Add PPI if indicated:

• Omeprazole 20 mg capsules (or equivalent)
• Take one capsule by mouth daily
• Dispense: 14 capsules

Patient Counseling Points

Instruct the patient to:

• Take with food to minimize GI upset
• Stop immediately and seek care for: black/tarry stools, severe abdominal pain, chest pain, shortness of breath, sudden weakness, or vision changes
• Avoid other NSAIDs (including over-the-counter ibuprofen, naproxen) while taking celecoxib
• Report any new ankle swelling or weight gain (signs of fluid retention)
• This is a short-term bridge to orthopedic evaluation, not long-term therapy

Common Pitfalls to Avoid

Do not prescribe celecoxib if:

• Patient has active cardiovascular disease or recent cardiac events
• Patient has aspirin allergy or sulfonamide allergy (celecoxib contains a sulfonamide moiety) 1
• Patient is in third trimester of pregnancy (can cause premature closure of ductus arteriosus) 5
• Patient has severe renal or hepatic impairment

Remember: While celecoxib has better GI safety than non-selective NSAIDs 4, 3, it is not risk-free. The CLASS trial showed celecoxib had significantly fewer ulcer complications (0.1/100 patient-years) compared to non-selective NSAIDs (0.8/100 patient-years) 3, but cardiovascular concerns remain, particularly at higher doses or in high-risk patients 8, 6.

Use the lowest effective dose for the shortest duration 4, 1. Your 14-day course is appropriate for bridging to specialist care, but emphasize this is not intended for chronic use without reassessment.